减毒活鳗弧菌疫苗在红鳍东方鲀中诱导高效免疫保护
研究评估了减毒活鳗弧菌疫苗MVAV6203对红鳍东方鲀的安全性与免疫保护效果。幼鱼和成鱼分别接种单剂量或50倍单剂量疫苗后均表现毒力减弱,且不影响体重;接种后多种细胞因子表达显著升高,攻毒后幼鱼和成鱼相对保护率分别为90.67%和80.31%。
要点
- 减毒活疫苗MVAV6203在幼鱼和成鱼中均表现毒力减弱,单剂量或50倍单剂量接种均安全。
- 疫苗接种不影响鱼体增重,与生理盐水对照组相比无显著生长差异。
- 攻毒后幼鱼和成鱼相对保护率分别为90.67%和80.31%,与细胞免疫应答相关。
核心结论
- 减毒活鳗弧菌疫苗MVAV6203适用于红鳍东方鲀,可诱导有效且安全的免疫保护以预防弧菌病。
研究设计与样本
- 研究评估了减毒活鳗弧菌疫苗MVAV6203在红鳍东方鲀幼鱼和成鱼中的毒力减弱、生长影响、细胞因子表达及攻毒保护效果。
主要发现
- 幼鱼和成鱼接种单剂量或50倍单剂量疫苗后均表现毒力减弱。
- 疫苗接种对鱼体增重无显著影响,接种组与生理盐水对照组之间生长无显著差异。
- 接种后促炎(IL-1β、TNFα、IL-6)、细胞免疫诱导(IL-12p35、IL-12p40、IL-18)、抗病毒/胞内病原杀伤(I-IFN-1、IFN-γ、Mx)、外周T细胞扩增与存活调控(IL-2、IL-7、IL-15)及抗原加工标志与抗炎(MHC I、IL-10)相关细胞因子表达显著升高。
- 攻毒后幼鱼相对保护率为90.67%,成鱼相对保护率为80.31%。
关键数值与推荐
- 幼鱼相对保护率为90.67%。
- 成鱼相对保护率为80.31%。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Tiger puffer (Takifugu rubripes) is becoming an economic promising aquaculture species in China. However, the development of Tiger puffer breeding industry is restricted by some serious aquatic disease such as vibriosis. An effective live attenuated vaccine MVAV6203 was developed in our previous studies by curing the virulence plasmid pEIB1 and unmarked inframe-deletion of the aroC gene from the virulent V. anguillarum. Here, we evaluated whether this live vaccine was suitable for Tiger puffer against disease caused by Vibrio genus. The live vaccine show virulence attenuation in both juvenile and adult fish vaccinated with either a single or high dose (50-fold single dose). In addition, administration of the live vaccine shew limited growth in fish and did not affect fish body weight significantly, with no adverse impact on growth between vaccinated and saline control fish. Furthermore, increased expression of cytokines involved in pro-inflammatory (IL-1β, TNFα and IL-6), cell-mediated immunity inducing (IL-12p35, IL-12p40 and IL-18), antiviral/intracellular pathogen killing (I-IFN-1, IFN-γ and Mx), peripheral T cell expansion and survival controlling (IL-2, IL-7 and IL-15) and antigen processing maker and anti-inflammatory (MHC I and IL-10) were elicited significantly after the vaccination. These cellular responses correlate with protection against virulent strain challenge and high RPS of 90.67% and 80.31% in juvenile and adult fish were obtained, respectively. These data indicated for the first time that the live attenuated V. anguillarum vaccine is suitably applied for the development of an effective and safe vaccine for prevention of vibriosis in Tiger puffer aquaculture industry.
引用
- Liu X, Jiao C, Ma Y, et al. A live attenuated Vibrio anguillarum vaccine induces efficient immunoprotection in Tiger puffer (Takifugu rubripes). Vaccine. 2018. PMID: 29429806. doi:10.1016/j.vaccine.2018.01.067
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。